New York, NY (PRWEB) February 27, 2013
The birth control safety advocates at DrugRisk.com are alerting women who have suffered side effects while using the IUD contraceptive Mirena of legal updates that could affect how and where hundreds of injury claims are handled.
“DrugRisk’s mission is to improve patient safety by providing the latest drug warnings, recalls, studies and legal news. Not only can patients use information to discuss options with their doctor, they can see others’ experiences and decide if they need legal advice,” explains DrugRisk representative Ryan Mayer.
DrugRisk has added the latest FDA AERS updates showing more than 47,000 patients have reported complications from the Mirena IUD.* Of these, 5079 involved dislocation and 1421 involved device migration, which can damage the uterine wall or other organs.* Over 6% of patients required hospitalization or Mirena removal via surgery.
The resource center has also learned that the FDA already warned Bayer about the marketing of Mirena in 2009, after they failed to disclose safety risks.**
With the number of patients filing a Mirena lawsuit increasing, plaintiffs filed a request that cases be consolidated to a special federal Multi-District Litigation court in Ohio.*** The petition estimates that, with more than 2 million users, hundreds of Mirena perforation cases could be filed.
Now, new information added to DrugRisk.com shows that the Joint Panel on Multi-District Litigation has scheduled a hearing for March 21, 2013 to decide whether cases will be consolidated to one court, and where that will be.****
Anyone who suffered perforation or required surgery while using a Mirena IUD is urged to speak with a lawyer about their legal rights. Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers who are already handling Mirena lawsuits.
For more information on the research, side effects and litigation news related to Mirena and other medical devices, or to speak with a lawyer, visit http://www.DrugRisk.com.
*FDA AERS Reports for Mirena through June 30, 2012 - drugcite.com/?q=mirena
**NDA 21-225, Mirena (levonorgestrel-releasing intrauterine system) MACMIS # 18166, 12/30/09
***In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780; harrismartin.com/media/uploads/documents/DRU-1301-27.pdf